[ADHEFAP: Clinical trial to evaluate an educational-behavioral telephone intervention by the primary care pharmacist to improve therapeutic adherence].

Autor:	Basagoiti Carreño B; Servicio de Farmacia de Atención Primaria, Dirección Asistencial Noroeste, Gerencia Asistencial de Atención Primaria de Madrid, Majadahonda, Madrid, España. Electronic address: blanca.basagoiti@salud.madrid.org., Díez Alcántara A; Servicio de Farmacia de Atención Primaria, Dirección Asistencial Noroeste, Gerencia Asistencial de Atención Primaria de Madrid, Majadahonda, Madrid, España., Escudero Vilaplana BM; Servicio de Farmacia de Atención Primaria, Dirección Asistencial Oeste, Gerencia Asistencial de Atención Primaria de Madrid, Móstoles, Madrid, España., Silva Riádigos GM; Servicio de Farmacia de Atención Primaria, Dirección Asistencial Oeste, Gerencia Asistencial de Atención Primaria de Madrid, Móstoles, Madrid, España., Benítez García B; Servicio de Farmacia de Atención Primaria, Dirección Asistencial Este, Gerencia Asistencial de Atención Primaria de Madrid, Alcalá de Henares, Madrid, España., Greciano V; Servicio de Farmacia de Atención Primaria, Dirección Asistencial Este, Gerencia Asistencial de Atención Primaria de Madrid, Alcalá de Henares, Madrid, España.
Jazyk:	Spanish; Castilian
Zdroj:	Atencion primaria [Aten Primaria] 2023 Aug; Vol. 55 (8), pp. 102656. Date of Electronic Publication: 2023 May 22.
DOI:	10.1016/j.aprim.2023.102656
Abstrakt:	Objective: Evaluate the improvement in therapeutic adherence of an intervention based on telephone monitoring by the primary care pharmacist. Design: Randomized open controlled trial. Location: This study was carried out in 2021 by a multidisciplinary team working with health professionals of thirteen health centers belonging to four health districts in Community of Madrid, Spain. Participants: These were patients (60-74 years) with polipharmacy classified as non-adherent according to the Morisky-Green test. Two hundred and twenty-four patients were originally enrolled, 87 of them were non-adherents. Of these, 15 were lost and 72 were finally randomized. Seventy-one patients completed the study (33 intervention group and 38 control group). Interventions: Patients randomized to the intervention arm were included in a follow-up telephone program consisting of an interview at months 1, 2, and 3 to improve adherence. The Morisky-Green test was repeated at month 4 to assess improvement. In the control group this test was only performed at month 4. Main Measurements: Adherence measured by Morisky-Green at baseline and at 4th month. Results: The 72.7% of patients in the intervention group became adherent while only 34.2% did in the control arm, being the difference 38.5% (95% CI: 17.1-59.9), statistically significant (P=.001). Conclusions: After a follow-up educational-behavioral telephone intervention in non-adherent patients by the primary care pharmacist, therapeutic adherence was improved statistically significantly in the intervention group compared with the control group. (Copyright © 2023. Publicado por Elsevier España, S.L.U.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu